COG5

component of oligomeric golgi complex 5, the group of Components of oligomeric golgi complex

Basic information

Region (hg38): 7:107201372-107564261

Previous symbols: [ "GOLTC1" ]

Links

ENSG00000164597NCBI:10466OMIM:606821HGNC:14857Uniprot:Q9UP83AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • COG5-congenital disorder of glycosylation (Strong), mode of inheritance: AR
  • COG5-congenital disorder of glycosylation (Strong), mode of inheritance: AR
  • COG5-congenital disorder of glycosylation (Strong), mode of inheritance: AR
  • COG5-congenital disorder of glycosylation (Supportive), mode of inheritance: AR
  • COG5-congenital disorder of glycosylation (Strong), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Congenital disorder of glycosylation, type IIiARHematologicAwareness of coagulopathies may be beneficial in terms of medical management, especially in situations such as surgeryAudiologic/Otolaryngologic; Biochemical; Hematologic; Neurologic; Ophthalmologic19690088; 23228021; 31572517; 32174980
Hepatic-metabolized agents should be avoided

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the COG5 gene.

  • COG5-congenital_disorder_of_glycosylation (670 variants)
  • Inborn_genetic_diseases (115 variants)
  • not_provided (87 variants)
  • not_specified (48 variants)
  • COG5-related_disorder (26 variants)
  • Craniosynostosis_syndrome (1 variants)
  • Congenital_disorder_of_glycosylation (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the COG5 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000006348.5. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
5
clinvar
165
clinvar
2
clinvar
172
missense
3
clinvar
2
clinvar
314
clinvar
14
clinvar
333
nonsense
22
clinvar
3
clinvar
1
clinvar
26
start loss
1
3
4
frameshift
16
clinvar
3
clinvar
2
clinvar
21
splice donor/acceptor (+/-2bp)
15
clinvar
15
Total 41 24 324 180 2

Highest pathogenic variant AF is 0.0000464777

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
COG5protein_codingprotein_codingENST00000297135 22362960
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
9.77e-200.35612564501031257480.000410
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.4834924631.060.00002315568
Missense in Polyphen104118.250.879531447
Synonymous-2.001921601.200.000007861691
Loss of Function1.753750.40.7340.00000258585

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.001110.00110
Ashkenazi Jewish0.000.00
East Asian0.0008700.000870
Finnish0.00009310.0000924
European (Non-Finnish)0.0003640.000360
Middle Eastern0.0008700.000870
South Asian0.0004600.000457
Other0.0003260.000326

dbNSFP

Source: dbNSFP

Function
FUNCTION: Required for normal Golgi function. {ECO:0000250}.;
Disease
DISEASE: Congenital disorder of glycosylation 2I (CDG2I) [MIM:613612]: A multisystem disorder caused by a defect in glycoprotein biosynthesis and characterized by under-glycosylated serum glycoproteins. Congenital disorders of glycosylation result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N- glycoproteins during embryonic development, differentiation, and maintenance of cell functions. Congenital disorder of glycosylation type 2I is characterized by mild neurological impairments. {ECO:0000269|PubMed:19690088}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Vesicle-mediated transport;Membrane Trafficking;Post-translational protein modification;Metabolism of proteins;Transport to the Golgi and subsequent modification;Asparagine N-linked glycosylation;Intra-Golgi traffic;COPI-mediated anterograde transport;ER to Golgi Anterograde Transport;Retrograde transport at the Trans-Golgi-Network;Intra-Golgi and retrograde Golgi-to-ER traffic (Consensus)

Recessive Scores

pRec
0.100

Intolerance Scores

loftool
0.980
rvis_EVS
-0.02
rvis_percentile_EVS
52.32

Haploinsufficiency Scores

pHI
0.693
hipred
N
hipred_score
0.277
ghis
0.534

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
E
gene_indispensability_pred
E
gene_indispensability_score
0.754

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Cog5
Phenotype

Gene ontology

Biological process
endoplasmic reticulum to Golgi vesicle-mediated transport;intra-Golgi vesicle-mediated transport;protein transport
Cellular component
Golgi membrane;nucleoplasm;Golgi apparatus;cytosol;membrane;Golgi transport complex;trans-Golgi network membrane
Molecular function
molecular_function;protein binding